ACT uses an embryonic stem-cell-removal technique that doesn’t destroy anything: It removes a single cell from embryos that are in the eight-cell stage--in other words, extremely early on. It’s identical to what’s done in in-vitro fertilization clinic for genetic testing of diseases like Tay-Sachs and Huntington’s Disease. "It’s a non-destructive, non-harmful method of extracting these cells and creating embryonic stem cells. There are thousands of babies born every year having this exact kind of genetic testing done," says ACT CEO Gary Rabin.
ACTC closed down a little at 0.082 on 8.4 million shares. The three month avg. volume is 5.2 million shares.
AAPL closed up $8.30 at $691.28 on 21.4 million shares. The three month avg. volume is 14 million shares.
Poor, poor Geron closed down just a little at $1.41 on 2.6 million shares. The three month avg. volume is 1,440,810 shares.
Good luck in this rigged casino,
No comments:
Post a Comment